Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Bladder Cancer
4 articles
Breakthrough Combo Therapy Revolutionizes Advanced Bladder Cancer Treatment
New drug combination shows superior survival benefit for advanced bladder cancer in global trial.
New Bladder Cancer Treatment Slashes Recurrence Rates: Promising Results from Egyptian Trial
Study shows neoadjuvant EMDA of mitomycin C before TURBT may reduce bladder cancer recurrence vs BCG alone.
Immunotherapy Combo Boosts Survival in Advanced Bladder Cancer
Adding nivolumab to chemotherapy improves outcomes for patients with metastatic urothelial carcinoma
Erdafitinib Outperforms Chemo for Advanced Bladder Cancer with FGFR Mutations
Erdafitinib improves survival vs. chemo in metastatic urothelial cancer with FGFR alterations